GeoVax files S-1 for resale of 11.4 million warrant shares tied to August inducement
The clinical-stage biotech registered shares for a selling stockholder while flagging going-concern doubts and cash runway into October 2026.
SEC filing
Latest
3 stories
Thursday, September 17
Friday, August 28
GeoVax completes warrant inducement, collects about $3.6 million
The company had existing warrant holders exercise their warrants for cash while issuing new warrants in exchange, according to an August 28, 2026 SEC filing.
SEC filing
Monday, July 27
GeoVax reaffirms Q4 start for GEO-MVA pivotal trial, reports $3.1 million cash
GeoVax said it kept working through operational steps for its EMA-backed GEO-MVA immunobridging study while advancing Gedeptin combination plans and narrowing quarterly losses.
SEC filing